| LYL1 |
LYL1: Protein lyl-1 |
ASCL2 |
ASCL2: Achaete-scute homolog 2 |
16.110 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
NHLH1 |
NHLH1, HEN1: Helix-loop-helix protein 1 |
16.110 |
Evidence |
|
| HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
TWIST1 |
TWIST1, TWIST: Twist-related protein 1 |
16.110 |
Evidence |
|
| HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
HAND2 |
HAND2, DHAND: Heart- and neural crest derivatives-expressed protein 2 |
16.110 |
Evidence |
O
|
| KCNQ3 |
KCNQ3: Potassium voltage-gated channel subfamily KQT member 3 |
KCNA3 |
KCNA3, RP11-284N8.2-001, hCG_1642166: Potassium voltage-gated channel, shaker-re |
16.110 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
ABCF1 |
IPI00013495 |
16.100 |
Evidence |
|
| MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
TCOF1 |
IPI00298696 |
16.100 |
Evidence |
|
| STIP1 |
STIP1: Stress-induced-phosphoprotein 1 |
CRKL |
CRKL: Crk-like protein |
16.100 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
16.100 |
Evidence |
|
| FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
HRG |
HRG: Histidine-rich glycoprotein precursor |
16.100 |
Evidence |
|
| MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
BAZ2A |
BAZ2A, KIAA0314, TIP5: Bromodomain adjacent to zinc finger domain protein 2A |
16.100 |
Evidence |
|
| IPO7 |
IPO7: Uncharacterized protein IPO7 |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
16.100 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
MAPK7 |
mitogen-activated protein kinase 7 isoform 1 |
16.100 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
VCPIP1 |
VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 |
16.100 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CASP8 |
IPI00305242 |
16.100 |
Evidence |
|
| FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
A2M |
A2M, FWP007: Alpha-2-macroglobulin precursor |
16.100 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
STAMBP |
STAMBP, AMSH: STAM-binding protein |
16.080 |
Evidence |
|
| SHB |
SHB: SH2 domain-containing adapter protein B |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
16.080 |
Evidence |
|
| IL1RAPL1 |
IL1RAPL1, OPHN4: X-linked interleukin-1 receptor accessory protein-like 1 precur |
MYD88 |
|
16.080 |
Evidence |
|
| ARNT2 |
ARNT2, KIAA0307: Aryl hydrocarbon receptor nuclear translocator 2 |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
16.080 |
Evidence |
|
| AHR |
AHR: Aryl hydrocarbon receptor precursor |
ARNT2 |
ARNT2, KIAA0307: Aryl hydrocarbon receptor nuclear translocator 2 |
16.080 |
Evidence |
|
| GABRR2 |
GABRR2: Gamma-aminobutyric acid receptor subunit rho-2 precursor |
CHRNA7 |
CHRNA7, NACHRA7: Neuronal acetylcholine receptor subunit alpha-7 precursor |
16.080 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
ID1 |
ID1, ID: DNA-binding protein inhibitor ID-1 |
16.080 |
Evidence |
|
| EIF4G3 |
EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 |
EIF5 |
EIF5: Eukaryotic translation initiation factor 5 |
16.060 |
Evidence |
|
| EIF4G3 |
EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 |
EIF4E |
EIF4E, EIF4EL1, EIF4F: Eukaryotic translation initiation factor 4E |
16.060 |
Evidence |
|
- 
-